Strabismus Completed Phase 4 Trials for Dexmedetomidine (DB00633)

Also known as: Squint / Strabismus NOS / Heterophoria / Binocular eye movement disorder NOS / Heterotropia / Heterophoria, unspecified / Binocular eye movement disorder / Heterotropia, unspecified / Unspecified disorder of binocular eye movements

IndicationStatusPhase
DBCOND0009706 (Strabismus)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01901588Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus SurgeryPrevention